India Steps Up Clinical Trial Oversight After Infant Death
Wyeth Pharmaceutical’s recent troubles in India have drawn new attention to the country’s problems enforcing clinical trial standards. In November 2008, an infant died during clinical trials for a Wyeth-manufactured pneumococcal vaccine. This prompted the Drugs Controller General of India (DCGI), India’s... Read More